Currently the most promising strategy seems to be a well-balanced low-calorie diet
For patients currently on Mounjaro who are interested in eventually transitioning to retatrutide, here is a realistic timeline based on available information: Phase 3 trials complete and data is analyzed
Company : FuturHealth Address : FuturHealth Inc 325 W Washington St Ste 2 - 944 San Diego, CA 92103 Email : [email protected] Phone Support : (831) 900-4723 Disclaimer General Disclaimer This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment
A notable study showcased that participants receiving GLP-1 agonists reported a mean weight loss ranging between 3.0 and 3.6 kg over six months
2 With rising off-label use of GLP-1s in PCOS, comparative evidence with metformin is needed to inform clinical practice and health policy
By clicking "Accept", you consent to our use of cookies.